ChartArt
Long

Array BioPharma Inc. can head towards $7

NASDAQ:ARRY   ARRAY BIOPHARMA INC
89 0 0
Array seems to have found support and could break upwards the next weeks, based solely upon on the StochRSI and the weekly moving average trend. Besides that the fundamentals also look good. Analysts are bullish on this stock:


Array BioPharma Inc. (NASDAQ:ARRY) should head towards $11.08 per share according to 6 Analysts in consensus. The higher price estimate target is at $15 according to the Analysts.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

Source: http://www.google.com/finance/company_news?q=arry


Entry: 5.9 USD
Stop Loss: 5.5 USD
1. Target: 7.0 USD
2. Target: 7.75 USD

P.S. A screenshot of the daily chart with my trend lines from the weekly chart:

snapshot
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out